FY2016 EPS Estimates for Alcentra Capital Corp. (ABDC) Raised by Zacks Investment Research
Alcentra Capital Corp. (NASDAQ:ABDC) – Zacks Investment Research boosted their FY2016 earnings estimates for shares of Alcentra Capital Corp. in a research note issued to investors on Monday. Zacks Investment Research analyst L. Thompson now forecasts that the brokerage will post earnings of $1.56 per share for the year, up from their prior forecast of $1.55.
A number of other analysts have also commented on ABDC. TheStreet lowered Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a research note on Monday, November 7th. Oppenheimer Holdings Inc. reissued a “market perform” rating on shares of Alcentra Capital Corp. in a research note on Monday, November 7th. Finally, Robert W. Baird lowered Alcentra Capital Corp. from an “outperform” rating to a “neutral” rating and cut their price target for the company from $13.00 to $12.00 in a research note on Monday, November 7th.
Shares of Alcentra Capital Corp. (NASDAQ:ABDC) opened at 12.28 on Thursday. Alcentra Capital Corp. has a 1-year low of $8.87 and a 1-year high of $13.47. The company’s 50-day moving average price is $12.80 and its 200-day moving average price is $12.38.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 5th. Investors of record on Saturday, December 31st will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 11.07%. The ex-dividend date is Wednesday, December 28th. Alcentra Capital Corp.’s dividend payout ratio is currently 1,046.23%.
In related news, insider David Scopelliti acquired 2,000 shares of the business’s stock in a transaction that occurred on Thursday, September 8th. The shares were bought at an average cost of $12.88 per share, with a total value of $25,760.00. Following the completion of the purchase, the insider now directly owns 4,600 shares in the company, valued at $59,248. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.47% of the stock is owned by corporate insiders.
Several institutional investors have recently bought and sold shares of the company. Confluence Investment Management LLC raised its position in Alcentra Capital Corp. by 0.8% in the second quarter. Confluence Investment Management LLC now owns 189,994 shares of the company’s stock worth $2,308,000 after buying an additional 1,456 shares in the last quarter. UBS Group AG raised its position in Alcentra Capital Corp. by 3.9% in the first quarter. UBS Group AG now owns 187,480 shares of the company’s stock worth $2,180,000 after buying an additional 6,975 shares in the last quarter. Advisors Asset Management Inc. raised its position in Alcentra Capital Corp. by 13.9% in the second quarter. Advisors Asset Management Inc. now owns 753,168 shares of the company’s stock worth $9,151,000 after buying an additional 92,064 shares in the last quarter. Moody National Bank Trust Division raised its position in Alcentra Capital Corp. by 50.3% in the second quarter. Moody National Bank Trust Division now owns 24,500 shares of the company’s stock worth $298,000 after buying an additional 8,200 shares in the last quarter. Finally, Oppenheimer & Co. Inc. raised its position in Alcentra Capital Corp. by 2.2% in the third quarter. Oppenheimer & Co. Inc. now owns 12,448 shares of the company’s stock worth $162,000 after buying an additional 268 shares in the last quarter. 44.23% of the stock is currently owned by institutional investors.
Alcentra Capital Corp. Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Stock Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related stocks with our FREE daily email newsletter.